Clinical Trials

Please read more below to learn more about our active trials and see which one might be the right fit for you. If you are interested in participating, please contact us on email at iptrials@health.ucsd.edu or call 858-207-0938.

Bipolar Efficacy Biomarkers for Accelerated Intermittent Theta Burst rTMS Trial

This study is for adults aged 18 to 70 years old that are experiencing treatment-resistant depression (Bipolar 1 or Bipolar 2 Depression), and involves theta burst stimulation (TBS) given 10 times per day for five days. This study is funded by the Milken Institute. 

Click here to read more about this study on ClinicalTrials.gov.

Individualized Neuromodulation for Anhedonic Depression (Wellcome Leap)

This study focuses on adults aged 18 to 80 years old who are suffering from treatment-resistant depression. This trial involves one week of accelerated rTMS given 10 times per day for five days. This study is funded by Wellcome Leap.

Click here to ead more about this study on ClinicalTrials.gov.

Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression

This study is for adults aged 18 to 70 that are experiencing treatment-resistant depression and suicidal ideation. This clinical trial involves one week of accelerated rTMS given 10 times per day for five days. This research is funded by the Brain and Behavior Research Foundation.

Click here to read more about this study on ClinicalTrials.gov.

Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST)

This study is for adults aged 18 years and older who are experiencing treatment-resistant depression, and involves up to 21 treatments (three sessions per week for seven weeks). Patients are assigned to MST or ECT. This study is funded by the National Institutes of Health.

Contact Us